Evidence map›Paper›PMID 38782980›Full record

ArticleScientific reports2024

Unraveling the role of natriuretic peptide clearance receptor (NPR3) in glomerular diseases.

Dina Dabaghie, Emmanuelle Charrin, Pernilla Tonelius, Birgitta Rosengren, Gizem Korkut, Anna B Granqvist, Mark Lal, Jaakko Patrakka

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dina Dabaghie *Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
Emmanuelle Charrin *Division of Pathology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
Pernilla ToneliusBioscience Renal, Cardiovascular, Renal and Metabolism (CVRM), R&D Biopharmaceuticals, AstraZeneca, Gothenburg, Sweden.
Birgitta RosengrenBioscience Renal, Cardiovascular, Renal and Metabolism (CVRM), R&D Biopharmaceuticals, AstraZeneca, Gothenburg, Sweden.
Gizem KorkutDivision of Pathology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden.
Anna B GranqvistBioscience Renal, Cardiovascular, Renal and Metabolism (CVRM), R&D Biopharmaceuticals, AstraZeneca, Gothenburg, Sweden.
Mark LalBioscience Renal, Cardiovascular, Renal and Metabolism (CVRM), R&D Biopharmaceuticals, AstraZeneca, Gothenburg, Sweden.
Jaakko PatrakkaDivision of Pathology, Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden. jaakko.patrakka@ki.se.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Natriuretic peptides (NPs) are cardio-derived hormones that have a crucial role in maintaining cardiovascular homeostasis. Physiological effects of NPs are mediated by binding to natriuretic peptide receptors 1 and 2 (NPR1/2), whereas natriuretic peptide receptor 3 (NPR3) acts as a clearance receptor that removes NPs from the circulation. Mouse studies have shown that local NP-signaling in the kidney glomerulus is important for the maintenance of renal homeostasis. In this study we examined the expression of NPR3 in kidney tissue and explored its involvement in renal physiology and disease by generating podocyte-specific knockout mice (NPR3

Indexed as

Mice, KnockoutPodocytesReceptors, Atrial Natriuretic FactorAnimalsDiabetic NephropathiesDisease Models, AnimalKidney DiseasesKidney GlomerulusLosartanMaleMiceRatsatrial natriuretic factor receptor CLosartanReceptors, Atrial Natriuretic Factor

Identifiers

PMID38782980
PMCPMC11116399

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.